Zhitong Finance App News, Da Ren Tang (600329.SH) announced that the company expects to achieve net profit of 620 million yuan to 660 million yuan in the half year of 2026, a year-on-year decrease of 68% to 66%.

Net profit attributable to owners of the parent company declined year-on-year, mainly due to the sale of 12% of the shares of the joint venture Sino-US Tianjin Schke Pharmaceutical Co., Ltd. (“Tianjin SmithKline”) to Helion (China) Co., Ltd. and Haleon CHSARL (CHE-102.429.188) in the same period last year, achieving disposal revenue of 1.54 billion yuan and net profit after tax of 1.31 billion yuan. There were no such non-recurring events during the reporting period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.